Use of intensity of light emitted from plasma, flame, spark or arc at a specific wavelength for chemical analysis of the sample is referred as atomic emission spectrometry (AES). Atomic emission spectrometry is used for quantitative analysis of an element in the chemical sample. Identity of the element depends on the wavelength of the atomic spectral line and quantity of the detected element depends upon intensity of the light emitted. Atomic emission spectrometry (AES) is widely used in life science, food and drug safety, petrochemical and forensic science industry for analysis of the samples for quality.
Development in the technology is resulting in increased availability of the portable and user friendly atomic spectroscopy instruments. In addition, technology advancement is also resulting in expansion of the application area of the atomic emission spectrometry (AES) market into biotechnology, pharmaceutical chemistry, environmental testing, and clinical applications including proteomics, tissue analysis and toxicology. Thus, technology advancement is observed to be the prime driver for the growth of the global atomic emission spectrometry market. While on the other hand, stringent regulatory norms and requirement of skilled personnel are some of the factors that are observed to be limiting the growth of the global atomic emission spectrometry market.
Geographically, the global atomic emission spectrometry market has been segmented into four major geographies namely, North America, Europe, Asia Pacific and Rest of the World (RoW). North America comprises cumulative atomic emission spectrometry market for the U.S and Canada. Europe comprises cumulative market of atomic emission spectrometry in Germany, Italy, France, Spain, and Rest of Europe (RoE). Asia Pacific comprises cumulative market of atomic emission spectrometry in China, India, Australia, New Zealand and rest of Asia Pacific (RoAPAC). Rest of the World (RoW) comprises atomic emission spectrometry market in Latin America, Middle East and Russia. Currently, Europe and North America are leading the global atomic emission spectrometry market. Highly developed research infrastructure, higher healthcare spending, availability of government funding and skilled professionals to perform the analytical process are some of the factors that are driving the atomic emission spectrometry market in Europe and North America. Asia Pacific atomic emission spectrometry market is anticipated to grow at the fastest CAGR during the forecast period 2014 to 2020.
Rapidly developing research and development (R&D) infrastructure, government support to boost the growth of the medical, biotechnology and pharmaceutical sectors in the respective country and increasing spending capacity are some of the factors that are anticipated to drive the growth of the atomic emission spectrometry market in Asia Pacific. China, India, Japan, Australia and New Zealand are the most attractive market for atomic emission spectrometry in the Asia Pacific owing to relatively developed regulatory framework, availability of skilled personnel and high awareness about the technique. Latin American countries including Mexico, Brazil and Argentina are anticipated to show significant growth compared to other economies in the RoW region. Some of the key players contributing to the global atomic emission spectrometry market include, Thermo Fisher Scientific, Inc., Perkin Elmer, Inc., Agilent Technologies, Inc., Bruker Corporation, Waters Corporation, Shimadzu Corporation, AB Sciex and others.